Table: Aska Pharmaceutical Holdings - 6-MTH group results

ASKA Pharmaceutical Holdings

04/11/2025 07:10

Nov 4 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             35.25               32.37            71.00    
                 (+8.9 pct)          (+2.3 pct)       (+10.7 pct) 
  Operating          2.65                3.35             6.00    
                 (-20.8 pct)         (+9.5 pct)       (+12.5 pct) 
  Recurring          2.66                3.31             6.00    
                 (-19.7 pct)         (+7.0 pct)       (+17.5 pct) 
  Net                2.23                2.56             5.00    
                 (-13.0 pct)         (-38.0 pct)      (-2.0 pct)  
  EPS             78.49 yen           90.36 yen       176.22 yen  
  Ann Div                             55.00 yen        55.00 yen  
  -Q2 div         27.00 yen           25.00 yen                   
  -Q4 div                             30.00 yen        28.00 yen  
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T